Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion type Assertion NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_head.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion description "[MC1R Arg(160)/Arg(160) homozygotes were at increased risk (P = 0.027, odds ratio = 1.94) while TYR A2/A2 homozygotes were at reduced risk of prostate cancer (P = 0.033, odds ratio = 0.48).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_provenance.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion evidence source_evidence_literature NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_provenance.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion SIO_000772 11720436 NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_provenance.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion wasDerivedFrom gad-20150221 NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_provenance.
- NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_assertion wasGeneratedBy ECO_0000203 NP72051.RAHam4mkcmo2eX4c6KgULG50UANQVoegqj2WTnN-Ctgc0130_provenance.